Caribou Biosciences, Inc. (CRBU) Tops Q1 EPS by 7c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q1 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.39 million versus the consensus estimate of $2.65 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Caribou Biosciences Inc. (CRBU) PT Lowered to $5 at BofA Securities
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results